BACKGROUND
Human immunodeficiency virus (HIV) causes progressive impairment of the body's cellular immune system leading to increased susceptibility to infections, tumors and fatal conditions of AIDS. HIV is an enveloped RNA virus, on infection the DNA the viral genome becomes integrated in the DNA of the infected cell ensuring permanent infection and replication of the virus. The virus becomes established with the cells bearing CD4 glycoprotein in their plasma membrane. The whole T cell population in the body begins to decline, leaving the patient open to opportunistic infection. A decrease in CD4+ Tlymphocyte counts is responsible for the profound immunodeficiencies that lead to various opportunistic infections in HIV infected patients. Since the beginning of the AIDS pandemic, opportunistic infections have been recognized as common complications of HIV infection. The spectrum of opportunistic infections in the HIV infected subjects varies from one region to another (1).
The aetiologic spectrum of enteric pathogens causing diarrhoea includes bacteria, parasites, fungi and viruses 2 . Gastrointestinal problems resulting from opportunistic parasitic infections in HIV and AIDS infected subjects often present as diarrhea and significant disease has been recorded in 50-96% of cases worldwide with 90% prevalence rate reported in Africa 3 . Either backed by HIV or independently, intestinal parasitic infections have continued to be major cause of morbidity and mortality in humans (4) . Diarrhoea accounts for 50 million deaths worldwide and it ranks third among diseases responsible for human mortality globally (5) . Intestinal parasitic infections are among the most common infections world-wide. It is estimated that some 3.5 billion people are affected, and 450 million are ill as a result of these infections (5) . The rate of infection is remarkably high in Sub-Saharan Africa, where the majority of HIV and AIDS cases are concentrated (6) . In developed countries diarrhea occurs in 30-60% of AIDS patients and 90% in the developing countries (7).
Diarrhea and weight loss are independent predictors of mortality (8) . Acute and chronic diarrhea has been associated with different species of gastrointestinal parasites, which are responsible for considerable morbidity and mortality in HIV/AIDS patients (9) . Many of the opportunistic infections that ultimately plague such individuals involve infectious agents that are normally checked by the mucosal barriers which include Cryptosporidium spp, Giardia lamblia, Entamoeba histolytica, Ascaris lumbricoides, hookworm infection, Schistosoma spp and Strongyloides stercoralis are important cosmopolitant intestinal parasites that are common among children and immunocompromised individual (10) . Parasitic infections in HIV-infected patients are common in many regions and populations across Nigeria and represent a lasting public health challenge. There are a number of studies on parasites among HIV/AIDS patients in Nigeria with different prevalence rates. Due to the importance of intestinal parasites in HIV+/AIDS patients and because there are only few studies regarding the prevalence of intestinal parasites and their association with CD4+ cell counts in this population are available in Jos. This study was carried out to determine the prevalence and parasitic profile of intestinal infections in HIV/AIDS patients in relation to their immunologic status.
MATERIALS AND METHODS

Study design
This cross sectional survey involved interviewing of the HIV/AIDS patients using structured a questionnaire and also laboratory analysis of stool specimen for protozoa and helminth from the respondents. The study was carried out in Vom Christian Hospital, located in Jos-south of Plateau State Nigeria. The APIN laboratory was established in 2007 and it renders services to people from surrounding towns and villages like Turu, Vwang, Kuru, Farin lamba, Bukuru and other environs. Patients were enrolled from the months of MarchApril 2010. Study Population Stool samples were obtained from a total of 205 people who were confirmed to be HIV positive and were enrolled for antiretroviral therapy. Questionnaires were administered to them to obtain their demographic characteristics and gender status. Ethical consideration Ethical approval was obtained from the research ethics committee for the Vom Christian hospital. Written informed consent was obtained from all the study participants, and human experimentation guidelines of the hospital were followed.
Sample collection
A total of 205 stool specimens were collected in labeled, clean, leak-proof and wide mouth plastic containers from the patients enrolled for the study. The most recent CD4 T-cells counts of the participants were obtained from their ART fellow-up record in the hospital. Sample processing Direct microscopy of smears was performed for the detection of ova, larvae, trophozoites as described by Cheesebrough (1999) and cysts of intestinal parasites and formol-ether concentration technique for helminthic ova and larva (12) . A drop of stool concentrate was also stained by modified ZiehlNeelsen staining technique for oocysts of Isospora belli, Cryptosporidium and Cyclospora species (13) .
RESULT
The prevalence of intestinal parasites among HIV/AIDS infected people in Jos was 61.9% with 3.1% having multiple parasites infection. More of the people who enrolled for the survey were women and they also had the highest prevalence of 40% intestinal parasites while men recorded a prevalence rate of 22% infection. Both male and female HIV/AIDS patients within the age range 30-39 had the highest prevalence rates of intestinal infection.
During this survey eight different species of intestinal parasites were identified from the population studied. Majority of the intestinal parasites were geohelminths which recorded a prevalence of 59.1%. Hookworm recorded the highest prevalence rate of 18.1% followed by Schistosoma mansoni with a prevalence of 16.5% while the lowest parasite reported was Trichuris trichiura with a prevalence rate of 6.3%. HIV/AIDS patients who who said their occupation was farming and house wives had the highest rates of intestinal parasites.
The minimum CD4+ cell count was 13cells/µl and the maximum count was 711cells/µl. the highest prevalence of parasites occurred in HIV/AIDS people with CD4+ cells between 101-200 cells/µl and those with counts below 100cells/µl. KEY : E-Entamoeba histolytica; A-Ascaris lumbricoides; C-Cryptosporidium parvum; S-Schistosoma mansoni; En-Entamoeba coli TTrichuris trichiura; H-Hookworm; Hy-Hymenolepsis nana 24 among HIV infected subjects. The varying prevalence rates may be due to geographical variation of the study locations and is likely to depend upon the endemicity of that particular parasite in the community (25) . In this study 3.1% of the HIV infected people had multiple intestinal parasitic infections lower than it was reported by Inabo et al (15) in Zaria. Female HIV patients had a higher prevalence rate of intestinal parasitic infection (40%) than the HIV infected men (21.9%). Gender was not significantly associated with the rate of parasitic infection in this study population (p=0.696). Akinbo et a (14) had reported that gender was significantly associated with the prevalence of intestinal parasitic infections among HIV-infected patients although that study found more HIV intestinal parasitic infection in men while Kipyegen et al (26) reported no significant association between intestinal parasitic infection and gender. Age was not a significant factor associated with parasitic infection in this study (p=0.066) even though in both male and female HIV infected patients, those within the age range 30-39 had the highest rate of intestinal parasites. Kipyegen et al (26) reported no significant association between age and parasitic infection.
The HIV/AIDS patients in this population had a higher prevalence of helminthes infections (59.1%) than protozoan infections (37.8%). This is not in consistent with most findings; Kipyegen et al (26) reported a higher prevalence of protozoan infections among HIV patients in Baringo, Kenya. Inabo et al (1) also reported higher rate of coccidian parasites than helminthes. Among the helminthes, hookworms were more prevalent (18.1%) followed by Schistosoma mansonii (16.5%). Kipyegen et al (26) reported hookworms as the least prevalent parasite in HIV infected subjects in in Kenya ((1.3%), Abaver et al (18) also reported Hookworms (8.5%) and S. mansonii (5.7%) as the most prevalent intestinal helminth in HIV infected patients in Toto, Nigeria. Akinbo et al (14) reported Ascaris lumbricoides (33.1%) to be the most prevalent intestinal parasite in HIV infected subjects in Benin followed by hookworm (20.6%). The prevalence of hookworm in this study population is lower than that reported in Benin. In Ilorin Nigeria S. stercolaris was the most prevalent helminth in HIV infected persons (27).
Entamoeba histolytica/dispar was the only pathogenic parasite found in this study (8.78% On the socioeconomic factors, occupation of the subjects was found to be a significant factor associated with the prevalence of HIV/AIDS coinfection among the respondents in Vom (p=0.001).House wives, farmers and Civil servants had 16.1%, 13.7% and 11.2% prevalence respectively. Akinbo et al (14) had also reported a significant association between parasitic infection and occupation among HIV patients in Benin Nigeria with artisans, farmers and security guards having high prevalent rates.
Out of the 127 subjects with HIV/AIDS and intestinal parasite co-infections, 22.1% had CD4 + T cell count ≥ 501 cells/µl, 33.1% had CD4 + T cell count between 200-500 cells/µl and 44.9% had CD4 + T cells ≤ 200 cells/µl. studies have reported that most infections with opportunistic parasites and pathogenic parasites were associated with CD4 + cells below 200 cells/µl. Even though most of the parasites isolated were in the group of patients who had CD4 + T cell counts below 200 cells/µl. This study shows that, parasite infection was not directly associated with CD4 T-cell counts, as parasite infection was observed in patients across all the ranges of CD4 cell counts however, the intensity of the infection may influence treatment outcome in patients who are immunocompromised.
